Buprenorphine
Buprenorphine during pregnancy improves outcomes for mothers, babies
HONOLULU — Buprenorphine treatment during pregnancy improved perinatal outcomes for women with opioid use disorder and their babies, compared with no treatment, according to a new study.
Q&A: APA enjoins DEA to maintain telehealth access for controlled medication
In January, the U.S. Drug Enforcement Administration announced new rules to make permanent expanded telehealth access that was established during the COVID-19 pandemic, particularly for individuals on controlled medications.
Low-dose buprenorphine initiation shows limited success among fentanyl users with OUD
Low-dose initiation of buprenorphine in an outpatient setting showed low rates of success among a cohort of adults with opioid use disorder who self-reported daily fentanyl use, according to a study published in JAMA Network Open.
Extended telemental health flexibilities ‘still far from an ideal outcome’
Congress recently extended Medicare telehealth flexibilities that waive a requirement for an in-person visit before a patient can receive mental health services via telehealth.
Methadone may provide a more durable treatment option for opioid addiction
Individuals receiving methadone for opioid use disorder had a lower risk for discontinuing treatment compared with the combination of buprenorphine and naloxone, study results published in JAMA showed.
Despite ‘proven efficacy,’ buprenorphine scripts remain low after opioid-related events
Buprenorphine use increased in EDs over the last decade but remained underused after opioid-related encounters, a cross-sectional study published in JAMA Network Open suggested.
Higher buprenorphine doses for opioid use disorder may lower risk for ED, inpatient visits
Higher doses of buprenorphine were associated with significantly lower rates of acute care utilization among adults with opioid use disorder compared with the FDA’s recommended dose, according to a study published in JAMA Network Open.
Similar, favorable results with prenatal buprenorphine/naloxone vs. buprenorphine alone
Pregnant women with opioid use disorder treated with buprenorphine combined with naloxone had similar and, in some cases, more favorable neonatal and maternal outcomes vs. treatment with buprenorphine alone, researchers reported in JAMA.
Q&A: ‘No reason’ buprenorphine should not be offered in pediatric EDs
A recently published case report summarized the successful initiation of buprenorphine treatment in two adolescents who presented to a pediatric ED with opioid withdrawal.
VIDEO: ‘Increasing evidence’ shows link between cannabis use and heart attack
BOSTON — In this video, an expert reviews current topics in addiction medicine, like ties between cannabis use and cardiovascular health, buprenorphine access and pre-operative alcohol assessments.